Zanamivir

Zanamivir (Relenza) can help to prevent and treat influenza (flu). This is an oral inhaler product containing zanamavir (a neuraminidase inhibitor) that is marketed by GlaxoSmithKline and the trade name for it is Relenza. The Center for Disease Control and Prevention says that there is no strain of influenze that has show resistance to Zanamivir.

Zanamivir is able to prevent the active protein in the influenza virus from being released from the host cell. As a result, it isn’t able to successfully be passed along to other people. If the medicine is given within 48 hours of symptoms then the flu can be reduced by 1 ½ days. That can make a significant difference for your immune system, your strength, and you getting back to your normal routine.

Individuals that have asthma can’t use Zanamivir as it could result in spasms of the bronchial region. Those with COPD also aren’t good candidates for the use of this medicine. When used correctly, there aren’t any real side effects to be worried about. Many people find that the nausea and vomiting caused by the flu are reduced. That also significantly reduces the risk of dehydration.

In addition to the use of Zanamivir, the same company has also been marketing an oral pill that is often given to patients that have been hospitalized for the flu. The use of either one of these medications is very important in today’s society. It can be a means of successfully preventing the spread of various types of infections that can be caused by either Influenza Virus A or Influenza Virus B.